BPC-157 Oral
Oral BPC-157 is investigated for stability through the GI tract and effects on mucosal healing, NSAID-induced gut injury, and systemic repair markers. Studies address peptide degradation kinetics and oral dose equivalence to parenteral administration in rodent models.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
BC500
Oral500mcg × 60 caps
$45
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord